Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling (Q82570547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

Niranjan Awasthi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

Margaret A Schwarz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Varun Verma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Clint Cappiello

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Roderich E Schwarz

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

10 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

38-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19002109%20AND%20SRC:MED&resulttype=core&format=json

Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

TUMOUR NECROSIS FACTOR RECEPTOR I (p55) IS UPREGULATED ON ENDOTHELIAL CELLS BY EXPOSURE TO THE TUMOUR-DERIVED CYTOKINE ENDOTHELIAL MONOCYTE- ACTIVATING POLYPEPTIDE II (EMAP-II)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

VEGF signalling: integration and multi-tasking in endothelial cell biology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Antiangiogenic tumour therapy: will it work?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Autocrine VEGF signaling is required for vascular homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

VEGF-receptor signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

VEGF receptor signalling - in control of vascular function

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.106

7 January 2021